Le Lézard
Classified in: Health
Subject: PDT

Convergent Dental announces commercial availability of SoleaŽ Protecttm to strengthen dental enamel using the SoleaŽ All-Tissue Dental Laser


Studies have shown that using Solea Protect in conjunction with fluoride is up to six times more effective at reducing mineral loss in tooth enamel than fluoride alone.

WALTHAM, Mass., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Tooth decay, also known as dental caries, can affect patients of all ages and is one of the top reasons for dental appointments. Convergent Dental, the power behind the SoleaŽ All-Tissue Dental Laser, is now helping dentists inhibit caries development with the commercial launch of SoleaŽ Protecttm. This new application for the Solea laser helps reduce mineral loss in dental enamel, protecting teeth against acid attack and caries development.

Preventing tooth decay benefits nearly everyone and Solea Protect gives providers easy-to-use technology that is convenient and effective for their patients. This new application is another example of the Solea laser's versatility and how Convergent Dental is pushing the future of dentistry forward.

Solea Protect is the result of decades of research in caries prevention using CO2 lasers. The treatment uses the Solea laser's novel 9.3-micron wavelength to gently heat the surface of tooth enamel, removing impurities that can weaken teeth. This process creates a strong, crystal-like tooth structure that is more resistant to decay (click here for the animation). When used in combination with fluoride, Solea Protect reduces mineral loss up to six times more than fluoride alone.[1] In a one-year clinical trial, 22% of patients who received only fluoride treatments required a caries restoration within the 12 months. Conversely, none of the patients (0%) who were treated with a combination of Solea Protect and fluoride required a restoration during the trial.[2]

"Convergent Dental is committed to driving innovation that elevates dental practices. Preventing tooth decay benefits nearly everyone and Solea Protect gives providers easy-to-use technology that is convenient and effective for their patients," said Robert L. Gershon, CEO of Convergent Dental. "This new application is another example of the versatility of the Solea laser and how Convergent Dental is pushing the future of dentistry forward."

With the addition of the Solea Protect treatment, the Solea laser enables dentists to offer both a unique preventative treatment and an anxiety-free experience when restorative work is required.

About Convergent Dental

Convergent Dental, Inc. (www.convergentdental.com) is a privately owned dental equipment and technology company. The Company's flagship product, SoleaŽ, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists can rely on.[3] Solea is a true breakthrough in dental laser technology that offers a completely different experience for both dentists and patients when compared to traditional instruments or any earlier laser treatment. Solea enables dentists to elevate their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.[4]

For more information, please visit www.convergentdental.com. Follow the company on Instagram, Facebook and LinkedIn.

[1] Badreddine AH, et al. Demineralization Inhibition by High-Speed Scanning of 9.3 ?m CO2 Single Laser Pulses Over Enamel. Lasers Surg Med. 2021 Jul;53(5):703-712.

[2] Rechmann P, et al. Fissure caries inhibition with a CO2 9.3-?m short-pulsed laser-a randomized, single-blind, split-mouth controlled, 1-year clinical trial. Clin Oral Investig. 2021 Apr;25(4):2055-2068.

[3] Based on report of 1000 procedures performed by Solea users. Documentation on file.

[4] Based on 2022 Annual Survey of Solea users. Documentation on file.

Media Contact

Caitlin D'Entremont, Convergent Dental, 1 5085005656, [email protected], https://www.convergentdental.com/

Twitter, LinkedIn

SOURCE Convergent Dental


These press releases may also interest you

at 06:45
YupMD.com, a premier telehealth platform, is transforming the weight loss industry by providing convenient, science-backed solutions for individuals seeking sustainable and effective results. Through its innovative approach, YupMD connects patients...

at 06:07
Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today presents on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington's...

at 00:18
The official brand behind Prime Biome, a product developed under Bioventra's portfolio of advanced formulations, has issued a public advisory regarding unauthorized third-party resellers misrepresenting the product online. Reports indicate that...

14 mar 2025
Adventist Health Simi Valley is proud to announce the opening of its newly designed clinic, a major step forward in providing high-quality, accessible healthcare to the community. This new facility combines two former clinics into one streamlined...

14 mar 2025
iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies, today announced the acquisition of TargImmune Therapeutics, a biotechnology company specializing in novel tumor targeted...

14 mar 2025
Willow Biosciences Inc. ("Willow" or the "Company") , a biotechnology company focused on industrial manufacturing of ingredients, announces that it has entered into a definitive agreement dated March 14, 2025 (the "Agreement") with an...



News published on and distributed by: